CareDx (CDNA) Competitors $14.99 +0.29 (+1.97%) Closing price 04:00 PM EasternExtended Trading$15.14 +0.15 (+1.00%) As of 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CDNA vs. PRVA, HTFL, VCYT, CON, SGRY, GRAL, ADUS, ARDT, LFST, and CELCShould you be buying CareDx stock or one of its competitors? The main competitors of CareDx include Privia Health Group (PRVA), Heartflow (HTFL), Veracyte (VCYT), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), GRAIL (GRAL), Addus HomeCare (ADUS), Ardent Health (ARDT), LifeStance Health Group (LFST), and Celcuity (CELC). These companies are all part of the "healthcare" industry. CareDx vs. Its Competitors Privia Health Group Heartflow Veracyte Concentra Group Holdings Parent Surgery Partners GRAIL Addus HomeCare Ardent Health LifeStance Health Group Celcuity Privia Health Group (NASDAQ:PRVA) and CareDx (NASDAQ:CDNA) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment. Do institutionals and insiders hold more shares of PRVA or CDNA? 94.5% of Privia Health Group shares are owned by institutional investors. 10.7% of Privia Health Group shares are owned by insiders. Comparatively, 4.4% of CareDx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings and valuation, PRVA or CDNA? CareDx has lower revenue, but higher earnings than Privia Health Group. CareDx is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrivia Health Group$1.74B1.80$14.39M$0.11232.09CareDx$340.83M2.34$52.55M$1.0214.70 Does the media refer more to PRVA or CDNA? In the previous week, Privia Health Group had 1 more articles in the media than CareDx. MarketBeat recorded 5 mentions for Privia Health Group and 4 mentions for CareDx. CareDx's average media sentiment score of 0.80 beat Privia Health Group's score of 0.50 indicating that CareDx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CareDx 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, PRVA or CDNA? Privia Health Group has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, CareDx has a beta of 2.37, meaning that its stock price is 137% more volatile than the S&P 500. Do analysts prefer PRVA or CDNA? Privia Health Group currently has a consensus target price of $28.91, suggesting a potential upside of 13.24%. CareDx has a consensus target price of $25.50, suggesting a potential upside of 70.11%. Given CareDx's higher probable upside, analysts clearly believe CareDx is more favorable than Privia Health Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Privia Health Group 1 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.71CareDx 1 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.38 Is PRVA or CDNA more profitable? CareDx has a net margin of 17.97% compared to Privia Health Group's net margin of 0.78%. CareDx's return on equity of 18.03% beat Privia Health Group's return on equity.Company Net Margins Return on Equity Return on Assets Privia Health Group0.78% 2.13% 1.25% CareDx 17.97%18.03%12.88% SummaryCareDx beats Privia Health Group on 9 of the 16 factors compared between the two stocks. Get CareDx News Delivered to You Automatically Sign up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDNA vs. The Competition Export to ExcelMetricCareDxMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$797.87M$8.26B$6.13B$10.46BDividend YieldN/A2.15%5.73%4.78%P/E Ratio14.7072.2385.1527.20Price / Sales2.3441.24574.61178.68Price / Cash10.5521.9237.3961.86Price / Book2.126.8212.396.65Net Income$52.55M$247.60M$3.32B$276.79M7 Day Performance1.77%-1.17%-0.24%-1.51%1 Month Performance5.71%-1.74%9.56%5.46%1 Year Performance-42.74%7.05%71.67%36.25% CareDx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDNACareDx4.3177 of 5 stars$14.99+2.0%$25.50+70.1%-44.2%$797.87M$340.83M14.70740PRVAPrivia Health Group3.2034 of 5 stars$24.14+0.2%$28.91+19.8%+43.2%$2.96B$1.74B219.471,140HTFLHeartflowN/A$33.22-0.7%$36.60+10.2%N/A$2.79BN/A0.00699VCYTVeracyte3.8049 of 5 stars$34.09-2.0%$40.90+20.0%+2.1%$2.74B$445.76M103.31790News CoverageCONConcentra Group Holdings Parent2.8339 of 5 stars$20.17-0.7%$27.75+37.6%-2.8%$2.60B$1.90B16.9511,250SGRYSurgery Partners3.4822 of 5 stars$19.79+0.3%$32.00+61.7%-33.8%$2.53B$3.11B-13.8415,000GRALGRAIL0.5644 of 5 stars$70.44+6.5%$56.67-19.6%+439.0%$2.38B$125.60M-5.371,360News CoverageGap UpADUSAddus HomeCare4.8038 of 5 stars$112.58-0.3%$137.50+22.1%-11.4%$2.08B$1.15B24.8549,703ARDTArdent Health3.6629 of 5 stars$14.10+0.4%$19.33+37.1%-25.3%$2.01B$5.97B7.7924,900News CoveragePositive NewsAnalyst ForecastLFSTLifeStance Health Group3.4746 of 5 stars$5.11+1.2%$8.50+66.3%-26.9%$1.96B$1.25B-102.2010,218News CoverageCELCCelcuity2.4223 of 5 stars$47.41+2.9%$56.50+19.2%+217.2%$1.95BN/A-13.7440 Related Companies and Tools Related Companies Privia Health Group Alternatives Heartflow Alternatives Veracyte Alternatives Concentra Group Holdings Parent Alternatives Surgery Partners Alternatives GRAIL Alternatives Addus HomeCare Alternatives Ardent Health Alternatives LifeStance Health Group Alternatives Celcuity Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDNA) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredIs *BSEM* Oversold??BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The com...Huge Alerts | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CareDx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CareDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
